Alyte is a social fitness app that enables users to engage in virtual workouts with friends through real-time video streaming and interactive features. This platform addresses the challenge of maintaining motivation and accountability in fitness routines by fostering social connections and shared experiences.

Arzeda utilizes Intelligent Protein Design Technology™, combining physics-based protein design and AI, to create novel proteins and enzymes that enhance product performance across various industries. This approach addresses the need for sustainable and efficient alternatives in food production, personal care, and materials, reducing environmental impact while improving functionality.

CuraFi embeds AI-powered decision support within the EMR to guide providers toward accurate coding, in-network referrals, and cost-effective therapies. The platform utilizes proprietary drug intelligence and machine learning models to benchmark drug utilization and predict cost changes for risk-bearing organizations. This integration optimizes clinical choices to lower costs and streamline care coordination at the point of service.

Docbot provides an AI-assisted imaging platform that enhances the detection and characterization of gastrointestinal diseases through real-time analysis of endoscopic video and multimodal data integration. This technology improves diagnostic accuracy and workflow efficiency for clinicians and researchers, addressing the challenges of disease measurement and monitoring in gastrointestinal care.

Provides 24/7 at-home intensive medical care for patients requiring ventilatory support, delivered by qualified nursing professionals with specialized training in non-hospital respiratory management. Serves patients in North Rhine-Westphalia, ensuring continuity of care through personalized treatment plans, telemedicine support, and close collaboration with healthcare providers.

Esteam utilizes AI and speech recognition technology to provide personalized reading assessments and tailored content for children, enhancing their reading skills. The platform addresses the challenge of literacy development by offering automated evaluations and custom stories that cater to each child's unique learning needs.

Filtricine, Inc. is developing Tality, a proprietary nutritional regimen designed to deprive cancer cells of non-essential amino acids while providing complete nutrition for patients undergoing cancer treatment. This approach aims to enhance patient quality of life and support cancer management through clinically investigated meal replacements, including soups, shakes, and bars.

Fluid provides an iPaaS integration platform that unifies APIs, data streams, enterprise systems, and AI agents into a single, low‑code orchestration hub. Its pre‑built connectors, AI‑driven data mapping, and real‑time analytics enable large enterprises to accelerate workflow creation, reduce integration errors, and gain actionable performance insights while maintaining PCI DSS‑level security.

Frontier Bio specializes in engineered tissue technology, employing bioprinting and scaffold design to produce functional human tissue models for biomedical research and therapeutic applications. This technology addresses the critical shortage of donor organs and eliminates the need for traditional animal testing in drug development.

Handl Health is an AI platform that utilizes proprietary models to analyze publicly available healthcare pricing data, enabling benefits consultants to evaluate carrier networks and provider costs effectively. By identifying potential savings and disruption risks, Handl Health enhances the design and management of health plans, resulting in significant cost reductions for clients.

Mesentech has developed a tissue-selective drug delivery system that utilizes novel chemistry to target pharmaceuticals specifically to musculoskeletal tissue, minimizing exposure to non-target organs. Their first clinical program focuses on delivering prostaglandin to enhance the body's regenerative processes for muscle and bone repair.

miRecule is developing Antibody RNA Conjugate (ARC) therapeutics using its proprietary DREAmiR™ platform, which leverages genomic patient data to create targeted RNA therapies for cancer and muscular dystrophy. The company addresses genetic abnormalities by designing tailored therapeutics that aim to alleviate the debilitating symptoms associated with these disorders.

Mitra Chem develops iron-based cathode materials for lithium-ion batteries, utilizing machine learning to streamline research and manufacturing processes, reducing the lab-to-production timeline by over 90%. The company addresses the underdeveloped North American battery materials supply chain, which is critical for achieving clean energy goals and reducing reliance on foreign sources.

QMENTA provides an integrated imaging platform designed to streamline workflows for clinical trials, research, and care providers. The system incorporates tools like automated PHI de-identification, secure cloud PACS integration, and over 50 AI imaging biomarkers. This unified infrastructure aims to accelerate decision-making, reduce operational costs, and enhance the accuracy of medical imaging analysis.

Smartlens, Inc. develops miLens, a non-invasive device that continuously monitors intraocular pressure (IOP) to provide real-time data for glaucoma management. Their THERmic technology delivers personalized microdose treatments based on the patient's diurnal IOP, addressing the challenge of inadequate monitoring and treatment of glaucoma patients.